The MASCC Risk Index - MedSchool
Sign up to start your free trial of MedSchool Premium!Get Started
The MASCC Risk Index is used to assess for risk of serious complications of febrile neutropaenia in patients with cancer. Low risk patients (≥21 points) may be safe for outpatient management, while high risk patients (<21 points) should be admitted and monitored closely.

Serious complications may include hypotension, respiratory failure, ICU admission, DIC, confusion, congestive cardiac failure, severe bleeding, arrhythmia or renal failure.
Click all that apply:
  • ≥21 points: low risk of serious complications; consider oral antibiotics or outpatient management with IV antibiotics
  • <21: High risk of serious complications; admit for IV antibiotics and close monitoring